Showing results (181-190 of 259) with videos related to
Sort By:
Pageof 26
International Pharmacopsychiatry|January 1, 1977
Antipsychotic effects, side effects and effective dosis of the butyrophenone lenperone (AHR 2277)B Woggon, A Franke, H Hucker, et al.International Pharmacopsychiatry|January 1, 1978
A review of nicotinic acid, N-methylated indoleamines and schizophreniaD Luchins, T A Ban, H E LehmannInternational Pharmacopsychiatry|January 1, 1978
Double-blind trial of thiothixene and chlorpromazine in acute schizophreniaK Rickels, H Byrdy, J Valentine, et al.International Pharmacopsychiatry|January 1, 1977
[Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)]W Obermair, W PöldingerInternational Pharmacopsychiatry|January 1, 1977
Plasma aldosterone and magnesium in serum and urine during lithium treatmentE B Pedersen, A Amdisen, S DarlingInternational Pharmacopsychiatry|January 1, 1978
Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trialJ N Nestoros, H E Lehmann, T A BanInternational Pharmacopsychiatry|January 1, 1977
[How blind is a double-blind trial really? Validity of controlled investigations]J Modestin, J HodelInternational Pharmacopsychiatry|January 1, 1977
Tandamine--a new norepinephrine reuptake inhibitor. Clinical, psychometric and quantitative EEG studies in depressed patientsB Saletu, P Krieger, J Grünberger, et al.International Pharmacopsychiatry|January 1, 1979
Erythrocyte electrolytes in recurrent affective disordersN J Birch, J C Goodwin, R P HullinInternational Pharmacopsychiatry|January 1, 1975
Marijuana-produced changes in pain tolerance. Experienced and non-experienced subjectsS L Milstein, K MacCannell, G Karr, et al.Pageof 26